AZNNYSEPharmaceutical PreparationsFiscal year ends December 31

ASTRAZENECA PLC

Financials through Q2 FY2026, quarter ended Jun 30, 2026

$163.95−1.46 (-0.88%)

Close on Oct 19, 2026

Market cap: $255.76B
P/E (TTM): 25.1
Dividend yield: 1.91%

ASTRAZENECA PLC balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Cash & Equivalents	5,711	5,488	5,840	6,166	6,329	7,832	5,369	4,831	3,324	5,018	6,240	–
Cash & Short-Term Investments	5,711	5,488	5,840	6,166	6,329	7,832	5,369	4,831	3,324	5,018	6,240	–
Receivables	15,177	12,972	12,126	10,521	9,644	7,022	5,761	5,574	5,009	4,573	6,622	–
Inventory	6,557	5,288	5,424	4,699	8,983	4,024	3,193	2,890	3,035	2,334	2,143	–
Total Current Assets	28,723	25,827	25,054	22,593	26,244	19,544	15,563	15,591	13,150	13,262	16,007	–
Property, Plant & Equipment	12,962	10,252	9,402	8,507	9,183	8,251	7,688	7,421	7,615	6,848	6,413	–
Operating Lease Right-of-Use Assets	1,741	1,395	1,100	942	988	666	647	722	–	–	–	–
Goodwill	21,242	21,025	20,048	19,820	19,997	11,845	11,668	11,707	11,825	11,658	11,800	–
Intangible Assets	37,846	37,177	38,089	39,307	42,492	20,947	20,833	21,959	26,188	27,586	22,646	–
Deferred Tax Assets	5,819	5,347	4,718	3,263	4,330	3,438	2,718	2,379	2,189	1,102	1,294	–
Total Assets	114,074	104,035	101,119	96,483	105,363	66,729	61,377	60,651	63,354	62,526	60,056	–
Accounts Payable	25,280	22,465	22,374	19,040	18,938	15,785	13,987	12,841	11,641	10,486	11,663	–
Current Portion of Long-Term Debt	2,460	2,007	4,614	4,964	1,273	1,536	1,597	999	1,397	–	–	–
Current Debt	3,104	2,337	5,129	5,314	1,660	2,194	1,822	1,754	2,247	2,307	916	–
Current Portion of Leases	382	339	271	228	233	192	188	–	–	–	–	–
Current Income Taxes Payable	1,084	1,406	1,584	896	–	–	–	–	–	–	–	–
Total Current Liabilities	30,617	27,866	30,542	26,293	22,594	20,307	18,117	16,292	16,383	15,256	14,869	–
Long-Term Debt	24,715	26,506	22,365	22,965	28,134	17,505	15,730	17,359	15,560	14,501	14,137	–
Long-Term Leases	1,421	1,113	857	725	754	489	487	–	–	–	–	–
Operating Lease Liabilities	1,803	1,452	1,128	953	987	681	675	720	–	–	–	–
Deferred Tax Liabilities	3,500	3,305	2,844	2,944	6,206	2,918	2,490	3,286	3,995	3,956	2,665	–
Total Liabilities	65,355	63,164	61,953	59,425	66,076	51,091	46,781	46,607	46,712	45,857	41,547	–
Total Debt	27,819	28,843	27,494	28,279	29,794	19,699	17,552	19,113	17,807	16,808	15,053	–
Common Stock	388	388	388	387	387	328	328	317	317	316	316	–
Additional Paid-In Capital	35,266	35,226	35,188	35,155	35,126	7,971	7,941	4,427	4,393	4,351	4,304	–
Retained Earnings	10,972	3,160	1,502	-574	1,710	5,299	2,812	5,683	8,221	8,140	11,834	–
Treasury Stock	-25	-68	-129	-112	–	–	–	–	–	–	–	–
Shareholders' Equity	48,667	40,786	39,143	37,037	39,268	15,622	13,127	12,468	14,960	14,854	18,490	–
Noncontrolling Interest	52	85	23	21	19	16	1,469	1,576	1,682	1,815	19	–
Total Equity	48,719	40,871	39,166	37,058	39,287	15,638	14,596	14,044	16,642	16,669	18,509	19,646

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 81.9%
Operating margin: 23.4%
Net margin: 17.4%
Return on equity, FY2025: 22.9%

Financial strength

Current ratio: 0.89
Debt to equity: 0.59
Debt to assets: 25.5%
Cash to current liabilities: 15.5%

Valuation

P/E ratio: 25.1
Price to sales: 4.35
Price to book: 5.09
Dividend yield: 1.91%